COVID–related strokes cause higher disability and death risk
Among the many hard lessons from the COVID-19 pandemic is that SARS-CoV-2, the virus that causes COVID-19 infections, can affect every organ system in...
COVID-19 increase risk of heart problems up to a year later
In a new study from Washington University in St. Louis, researchers found that people who have had COVID-19 are at increased risk of developing...
New antiviral drug combo highly effective against COVID-19
In a new study from the University of Pennsylvania, researchers found a powerful combination of antivirals to treat COVID-19.
They found combining the drug brequniar...
COVID-19 infection may boost your antibodies for up to 20 months
In a new study from the University of California, Los Angeles, researchers found in people who have already had COVID-19, the natural antibodies may...
Two doses of COVID-19 vaccine may protect against long COVID
In a new study from Bar-Ilan University, researchers found a major reduction in the most commonly-reported long-term symptoms of COVID-19 among individuals vaccinated with...
This new COVID-19 drug could effectively treat severe disease
In a new study from Avalo Therapeutics, researchers found a much higher proportion of hospitalized patients with COVID-19 remained alive and free of respiratory...
Scientists find existing drugs that may reduce death in COVID-19
Inflammation is a defense mechanism of the body to fight pathogens. However, when it is widespread and excessive, it can aggravate the pathology and...
COVID-19 Boosters: When, Which, How
More Americans seem to be heeding the latest scientific evidence pointing to COVID-19 booster shots as a boon to our immune systems and as...
40% of U.S. adults suffer from heart problems in COVID pandemic
In a new study from the Cleveland Clinic, researchers found 4 in 10 Americans say they've had at least one heart-related issue during the COVID-19...
1 in 10 people may still be infectious for COVID after ten days
In a new study from the University of Exeter, researchers found one in 10 people may have clinically relevant levels of potentially infectious SARS-CoV-2...